An intervention can increase serious illness conversations and reduce the use of systemic therapy at the end of life in patients with cancer.
Compared with the general population, survivors of childhood and adolescent cancers have an increased risk of 6 major psychiatric disorders.
Researchers sought to determine whether survivors of gynecologic cancers had a higher risk of sexual dysfunction, compared with cancer-free women, and the risk factors for sexual dysfunction.
A deep learning model called Sybil can predict a person’s risk of lung cancer using a single low-dose CT scan, a study suggests.
Prostate cancer has one of the largest racial disparities in outcomes between Black and White patients, according to investigators.
The IMbrave050 study included 662 patients with HCC at high risk for recurrence after surgical resection or ablation with curative intent.
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.
Changes in treatment have led to improvements in overall survival for US patients with rectal cancer, a study suggests.
Lumoxiti was approved by the FDA in September 2018 for the treatment of adults with relapsed or refractory hairy cell leukemia.
Incidence and mortality rates for major genitourinary cancers differ according to sex, race/ethnicity, and geographic region.
ZB131 is a proprietary monoclonal antibody designed to target cancer-specific plectin with high affinity and specificity.
Awareness of factors that cause cancer is especially poor among people who reject vaccines, prefer alternative medicine, or believe conspiracy theories.
Researchers investigated the effects of receiving vs not receiving an invitation to undergo a screening colonoscopy on colorectal cancer risk.
Tobacco smoking is the most important modifiable factor associated with bladder cancer risk, according to investigators.
Krazati is a highly selective and potent oral small molecule inhibitor of KRASG12C.
The approval was based on data from a phase 2 study that included 49 patients with unresectable or metastatic ASPS.
Neither a higher dose of daunorubicin nor a second induction cycle improved outcomes in fit patients with newly diagnosed acute myeloid leukemia.
Radiation therapy for prostate cancer is significantly associated with more than twice the risk for bladder cancer compared with radical prostatectomy, a study found.
Researchers sought to determine prevalence of telemedicine use for initial consultations and its influence on clinical trial enrollment.
In preclinical studies, WP1122 has shown to increase cellular uptake of 2-DG, increase drug half-life, and increase the ability to cross the blood brain barrier.